Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;8(21):e1900968.
doi: 10.1002/adhm.201900968. Epub 2019 Oct 8.

Models of the Gut for Analyzing the Impact of Food and Drugs

Affiliations
Review

Models of the Gut for Analyzing the Impact of Food and Drugs

Chiara Anna Maria Fois et al. Adv Healthc Mater. 2019 Nov.

Abstract

Models of the human gastrointestinal tract (GIT) can be powerful tools for examining the biological interactions of food products and pharmaceuticals. This can be done under normal healthy conditions or using models of disease-many of which have no curative therapy. This report outlines the field of gastrointestinal modeling, with a particular focus on the intestine. Traditional in vivo animal models are compared to a range of in vitro models. In vitro systems are elaborated over time, recently culminating with microfluidic intestines-on-chips (IsOC) and 3D bioengineered models. Macroscale models are also reviewed for their important contribution in the microbiota studies. Lastly, it is discussed how in silico approaches may have utility in predicting and interpreting experimental data. The various advantages and limitations of the different systems are contrasted. It is posited that only through complementary use of these models will salient research questions be able to be addressed.

Keywords: gut models; human intestine; inflammatory bowel disease; intestine-on-a-chip; microfluidics.

PubMed Disclaimer

References

    1. a) T. K. Soderborg, J. E. Friedman, Microb. Cell 2019, 6, 102;
    1. b) M. Maguire, G. Maguire, Rev. Neurosci. 2019, 30, 179.
    1. a) M. C. Houser, M. G. Tansey, npj Parkinson's Dis. 2017, 3, 3;
    1. b) A. I. Petra, S. Panagiotidou, E. Hatziagelaki, J. M. Stewart, P. Conti, T. C. Theoharides, Clin. Ther. 2015, 37, 984;
    1. c) J. I. Campos Acuña, D. Elgueta, R. Pacheco, Front. Immunol. 2019, 10, 239.

Publication types

LinkOut - more resources